PRODUCT

CHO Pharma has applied its innovative and proprietary glycan-based technology platforms to develop first-in-class therapeutics and diagnostics for the unmet clinical needs. There are a total of 7 products in the development pipeline that centered on the disease area in oncology, immunology and infection.